SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCCN.L Regulatory News (FCCN)

  • There is currently no data for FCCN

Form 8.5 (EPT/RI)

26 Oct 2021 10:05

RNS Number : 2796Q
Singer Capital Markets Sec Ltd
26 October 2021
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

French Connection Group PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

A consortium comprising Apinder Singh Ghura, Amarjit Singh Grewal and KJR Brothers Limited

(d) Date dealing undertaken:

25 October 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 1P

 

 

Purchase

 

52,019

 

29.4p

 

29.26p

 

ORD 1P

 

 

Sale

 

84,500

 

29.4p

 

29.4p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

26 October 2021

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUNRKRAVURURA
Date   Source Headline
11th Jul 20084:26 pmRNSJapan Joint Venture: Update
3rd Jun 200811:46 amRNSChange of Adviser
23rd May 20084:05 pmRNSResult of AGM
21st May 200811:15 amRNSInterim Management Statement
25th Apr 20089:32 amRNSBlocklisting Interim Review
25th Apr 20089:04 amRNSAnnual Information Update
9th Apr 20084:43 pmRNSDirector/PDMR Shareholding
12th Mar 20087:01 amRNSPreliminary Results
11th Feb 20081:39 pmRNSAppointment of director
11th Feb 200812:42 pmRNSNotice of Preliminary Results
20th Nov 200712:02 pmRNSHolding(s) in Company
12th Nov 20077:45 amRNSInterim Management Statement
29th Oct 20072:12 pmRNSHolding(s) in Company
23rd Oct 200712:16 pmRNSBlocklisting Interim Review
11th Sep 20077:02 amRNSInterim Results
23rd Jul 20077:00 amRNSNotice of Results
12th Jul 200710:38 amRNSHolding(s) in Company
17th May 20075:16 pmRNSResult of AGM
16th May 20077:04 amRNSInterim Management Statement
2nd May 200711:54 amRNSDirector/PDMR Shareholding
25th Apr 200711:13 amRNSBlocklisting Interim Review
24th Apr 20075:17 pmRNSAnnual Information Update
30th Mar 20074:48 pmRNSTotal Voting Rights
22nd Mar 20079:20 amRNSHolding(s) in Company
14th Mar 20072:18 pmRNSHolding(s) in Company
14th Mar 20077:02 amRNSFinal Results
8th Feb 20072:14 pmRNSNotice of Results
29th Dec 200611:01 amRNSTotal Voting Rights
15th Dec 200612:28 pmRNSTotal Voting Rights
31st Oct 20065:35 pmRNSBlocklisting Interim Review
15th Sep 20063:50 pmRNSHolding(s) in Company
14th Sep 20063:52 pmRNSHolding(s) in Company
12th Sep 200610:39 amRNSInterim Results - Replacement
12th Sep 20067:00 amRNSInterim Results
6th Sep 200610:00 amRNSHolding(s) in Company
24th Aug 20064:48 pmRNSNotice of Results
4th Jul 20064:32 pmRNSHolding(s) in Company
30th May 20064:03 pmRNSHolding(s) in Company
24th May 20065:00 pmRNSHolding(s) in Company
10th May 20067:00 amRNSAGM Statement
25th Apr 20064:44 pmRNSBlocklisting Interim Review
30th Mar 200611:14 amRNSHolding(s) in Company
14th Mar 20067:04 amRNSFinal Results
23rd Feb 200612:26 pmRNSHolding(s) in Company
9th Feb 20062:55 pmRNSNotice of Results
7th Feb 20065:02 pmRNSHolding(s) in Company
23rd Dec 200512:04 pmRNSPROPERTY DISPOSAL
23rd Dec 20057:00 amRNSHolding(s) in Company
9th Dec 20058:00 amRNSTrading Statement
11th Nov 20055:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.